Storage typically requires refrigeration before first use and room-temperature windows afterward, following the specific product label
Regulatory agencies, including the US Food and Drug Administration, the European Medicines Agency, and the Pharmaceuticals and Medical Devices Agency, require extensive Phase III clinical trials, immunogenicity assessments, and comprehensive Chemistry, Manufacturing, and Controls data before approving new GLP-1 therapies or label expansions
CLINICALLY-FORMULATED BRIGHTENING COMPLEX: Our 3% Glutathione (reduced L-form) paired with 10% stabilised Vitamin C and 2% Alpha Arbutin works synergistically to visibly reduce dark spots, pigmentation, tan, and uneven skin tone with regular twice-daily use
Severe stomach pain that radiates to your back requires immediate medical attention